Skip to content

+358 20 7446 800 

  • English
  • Suomi

Search

Show search form

Medfiles
  • Company
    • About us
    • History
    • Medfiles’ team leaders
    • Management team
  • Our Services
        • Human Medicines
          • Regulatory Affairs
            • CMC
            • New Marketing Authorisations
            • Marketing Authorisation Maintenance
            • Local Regulatory Affairs
          • Pharmacovigilance
            • PV System Set Up
            • Post-Authorisation
            • ICSR
            • QPPV
            • Medical Information
          • Clinical Trials
            • Clinical Trial Safety
        • Veterinary Medicines
          • Marketing Authorisation & PV Readiness
          • Regulatory Affairs
            • CMC
            • New Marketing Authorisations
            • Marketing Authorisation Maintenance
            • Local Regulatory Affairs
          • Pharmacovigilance
            • PV System Set Up
            • Post-Authorisation
            • Adverse Event Prosessing
            • QPPV
        • Medical Device & IVDS
          • Quality & Regulatory
            • QMS
            • Technical Documentation
            • Clinical and Performance Evaluations
            • Registrations
            • Post-Market Services
            • Labelling, Translations & Marketing Materials
          • Clinical Investigations and Performance Studies
          • Post-Authorisation & Clinical Vigilance
        • Drug-device combinations
          • Strategy and classification
          • Development, documentation and regulatory alignment
          • Clinical trials and investigations
          • CMC
          • Approvals and conformity
          • Safety & PMS
          • Lifecycle management
        • Food
          • Novel Foods
          • GRAS, NDI and FAP
          • Health Claims
          • Food and Food Supplement Labelling and Marketing Materials
          • FSGs and FSMPs
          • Regulatory Positioning and Strategies
          • Clinical Studies
        • Feed
          • Regulatory Positioning and Strategies
          • Feed Material and Additive Registrations
          • GRAS and FAP
          • Labelling and Marketing Materials
          • Feed for Particular Nutritional Purposes
  • Insights
  • Careers
  • Contact us
    • Contact form
    • Contact our units
    • Offices
    • Invoicing

Product: Food

  • 30 years of trusted regulatory expertise in the Baltics and EU

    20.05.2026

    Medfiles OÜ celebrates 30 years in business
  • Free webinar: Novel food classification and route to novel food authorisation in the EU

    04.05.2026

    Novel food classification and route to novel food authorisation in the EU
  • Free webinar: Q&A on termination of self-affirmed GRAS pathway

    28.04.2026

    GRAS and NDI
  • GRAS reform in the US is evolving – the latest developments

    07.04.2026

    GRAS reform in the US
  • UK-EU SPS Agreement: What could alignment with EU rules mean for GB market authorisations of food and feed products

    13.03.2026

    UK–EU SPS Agreement
  • European Biotech Act: what it means for EU food and feed regulation

    10.02.2026

    European Biotech Act
  • Food and feed ingredients and additives in the United States: is the self-affirmed GRAS pathway coming to an end

    29.01.2026

    self-affirmed GRAS
  • Food supplements in 2026: What will shape the European market this year?

    21.01.2026

  • Free webinar: How to Register Food Ingredients and Dietary Supplements for the US Market: GRAS and NDI Explained

    08.01.2026

    GRAS and NDI
Previous 1 2 3 4 5 Next
Medfiles - Securing a healthier tomorrow

© 2026 Copyright Medfiles.
All rights reserved.

Privacy Policy
Notification Channel

WDB Group

Services

Human medicine
Veterinary medicine
Medical Device & IVD
Drug-device combinations
Food
Feed

Contact

Rajatorpantie 41 C, FI-01640 Vantaa, Finland
VAT: FI10475691

+358 20 7446 800

Contact form
Subscribe to our Newsletter

© 2026 Medfiles • Built with GeneratePress